Lectures on the morbid anatomy of the serous and mucous membranes.

No more published.

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts

Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.

Staphylococcus epidermidis as a cause of bacteremia

Staphylococcus epidermidis is a biofilm-producing commensal organism found ubiquitously on human skin and mucous membranes, as well as on animals and in the environment. Biofilm formation enables this organism to evade the host immune system. Colonization of percutaneous devices or implanted medical devices allows bacteria access to the bloodstream. Isolation of this organism from blood cultures may represent either contamination during the blood collection procedure or true bacteremia. S. epidermidis bloodstream infections may be indolent compared with other bacteria. Isolation of S. epidermidis from a blood culture may present a management quandary for clinicians. Over-treatment may lead to patient harm and increases in healthcare costs. There are numerous reports indicating the difficulty of predicting clinical infection in patients with positive blood cultures with this organism. No reliable phenotypic or genotypic algorithms currently exist to predict the pathogenicity of a S. epidermidis bloodstream infection. This review will discuss the latest advances in identification methods, global population structure, pathogenicity, biofilm formation, antimicrobial resistance and clinical significance of the detection of S. epidermidis in blood cultures. Previous studies that have attempted to discriminate between invasive and contaminating strains of S. epidermidis in blood cultures will be analyzed.

The physiological and behavioral responses of steers to gaseous ammonia in simulated long distance transport by ship.

Ammonia (NH3) can accumulate in high density cattle accommodation during live export shipments and could potentially threaten the animals' health and welfare. The effects of 4 NH3 concentrations, control (<8), 15, 30, and 45 ppm, on the physiology and behavior of steers were recorded. The animals were held for 12 d under a micro-climate and stocking density similar to shipboard conditions experienced on voyages from Australia to the Middle East during the northern hemispheric summer. In bronchoalveolar lavage samples, ammonia increased (P < 0.05) macrophage activity in proportion to NH3 concentration and it increased (P < 0.05) neutrophil percentage at 30 and 45 ppm, indicating active pulmonary inflammation. It also increased (P < 0.05) lacrimation, nasal secretions and coughing, particularly at 45 ppm, indicating that the NH3 was irritating the mucous membranes of the eyes, nasal cavity and respiratory tract. Ammonia had no effect (P > 0.05) on hematological parameters or body weight. Twenty-eight days after exposure to NH3, the steers' pulmonary macrophage activity and neutrophil levels had returned to normal. It was concluded that ammonia concentrations of 30 and 45 ppm induced temporary inflammatory responses which indicate an adverse effect on the welfare of steers.

Molecular Details of Serum Resistance of Yersinia enterocolitica

In complement activation, Factor H (FH) and C4b-binding protein (C4bp) are the key regulators that prevent the complement cascade from attacking host tissues. Some bacteria may bind and deposit these regulators on their own surfaces and thus provide themselves with an efficient means to avoid complement activation. In consequence, bacteria resist complement-mediated lysis and opsonin-dependent phagocytosis. This study has demonstrated that Y. enterocolitica, similar to many other pathogens, recruits both FH and C4bp to its surface to ensure protection against the complement-mediated killing. YadA and Ail, the most crucial serum resistance factors of Y.enterocolitica, mediate the binding of FH and C4bp. FH - YadA interaction involves multiple higher structural motifs on the YadA stalk and the short consensus repeats (SCRs) of the entire polypeptide chain of FH. The Ail binding site on FH has been located to SCRs 6 and 7. The binding site for FH on Ail, however, remains undetermined. Both YadA- and Ail-bound regulators display full cofactor activity for FI-mediated cleavage of C3b/C4b. FH/C4bp-binding characteristics do, however, differ between YadA and Ail. In addition, Ail captures the regulators only in the absence of blocking lipopolysaccharide O-antigen and outer core, whereas YadA binds FH/C4bp independent of the presence of other surface factors Independent of mode of binding, however, YadA and Ail provide Y. enterocolitica a means to avoid complement-mediated lysis, enhancing chances for the bacteria to survive in the host during various phases of infection.

Staphylococcus haemolyticus e Staphylococcus epidermidis isolados de fômites de origem hospitalar: perfis de resistência aos agentes antimicrobianos e produção de biofilme

Os Staphylococcus coagulase-negativos (SCN) são encontrados na pele e mucosas de seres humanos e outros animais, já que algumas espécies são parte constituinte da microbiota normal destes mesmos sítios, e podem constituir um reservatório para SCN. A espécie Staphylococcus epidermidis, é reconhecida como grande oportunista e agente de graves infecções nosocomiais e comunitárias, além de associado com infecções em pacientes submetidos a implantes com dispositivos médicos, e a espécie Staphyloccus haemolyticus é a segunda espécie mais isolada de hemoculturas humanas, sendo uma das espécies que apresenta elevada resistência aos antimicrobianos. O presente estudo teve como objetivo principal investigar a presença de SCN em fômites (estetoscópios, termômetros e esfigmomanômetros) no ambiente hospitalar, identificar as espécies S. haemolyticus e S. epidermidis e correlacionar seus perfis de resistência aos antimicrobianos com a capacidade de produção de biofilme. A técnica de multiplex-mPCR foi empregada na determinação das espécies e a fenotipagem foi realizada pelos testes fenotípicos convencionais. Os perfis de resistência aos antimicrobianos foram verificados através do teste de disco-difusão, determinação da CIM (oxacilina e vancomicina), determinação da CBM e presença do gene mecA. A capacidade de produção de biofilme foi investigada pelos testes do Ágar Vermelho do Congo e ensaios de aderência em superfícies abióticas (poliestireno e vidro) na presença e ausência de oxacilina e vancomicina, além da PCR para o gene icaAD. Os resultados demonstraram que pelos testes bioquímicos convencionais, a espécie mais encontrada foi S. epidermidis (43,5%). Após a confirmação pela técnica de PCR, 29 amostras (82%) foram identificadas como S. epidermidis, e 6 amostras (18%) foram identificadas como S. haemolyticus. Todas as amostras foram multirresistentes, oxacilina resistentes e vancomicina sensíveis, sendo que apenas 5 amostras S. epidermidis (17,2%) foram tolerantes a oxacilina. A presença do gene mecA foi detectada em 71,4% das amostras. Apesar da maioria das amostras ter apresentado capacidade de produzir slime e/ou biofilme não foi observada total correlação com a presença do gene icaAD enfatizando a natureza multifatorial da produção de biofilme. As amostras aderiram melhor ao esfigmomanômetro, e também, neste fômites, foi encontrado a maior porcentagem de amostras positivas para a produção de slime. Para aderência ao vidro e aderência ao poliestireno não foi encontrada correlação com os fômites. Foram isoladas amostras S. epidermidis de todos os sítios hospitalares estudados e S. haemolyticus só não foi encontrado em Enfermaria de Clínica Médica. Em relação aos fômites, S. epidermidis foi encontrado em todos os fômites estudados, e S. haemolyticus, apenas foi encontrado em esfigmomanômetro e em outros fômites. Os fômites estão servindo como fontes de transmissão e disseminação de micro-organismos, sendo necessário maiores estudos a respeito.

Supra-treatment threshold neonatal jaundice: Incidence in HIV-exposed compared to non-exposed neonates at Queen Elizabeth Central Hospital in Blantyre, Malawi

INTRODUCTION: Jaundice is the yellowish pigmentation of the skin, sclera, and mucous membranes resulting from bilirubin deposition. Children born to mothers with HIV are more likely to be born premature, with low birth weight, and to become septic-all risk factors for neonatal jaundice. Further, there has been a change in the prevention of mother-to-child transmission (PMTCT) of HIV guidelines from single-dose nevirapine to a six-week course, all of which theoretically put HIV-exposed newborns at greater risk of developing neonatal jaundice.

AIM: We carried out a study to determine the incidence of severe and clinical neonatal jaundice in HIV-exposed neonates admitted to the Chatinkha Nursery (CN) neonatal unit at Queen Elizabeth Central Hospital (QECH) in Blantyre.

METHODS: Over a period of four weeks, the incidence among non-exposed neonates was also determined for comparison between the two groups of infants. Clinical jaundice was defined as transcutaneous bilirubin levels greater than 5 mg/dL and severe jaundice as bilirubin levels above the age-specific treatment threshold according the QECH guidelines. Case notes of babies admitted were retrieved and information on birth date, gestational age, birth weight, HIV status of mother, type of feeding, mode of delivery, VDRL status of mother, serum bilirubin, duration of stay in CN, and outcome were extracted.

RESULTS: Of the 149 neonates who were recruited, 17 (11.4%) were HIV-exposed. One (5.88%) of the 17 HIV-exposed and 19 (14.4%) of 132 HIV-non-exposed infants developed severe jaundice requiring therapeutic intervention (p = 0.378). Eight (47%) of the HIV-exposed and 107 (81%) of the non-exposed neonates had clinical jaundice of bilirubin levels greater than 5 mg/dL (p < 0.001).

CONCLUSIONS: The study showed a significant difference in the incidence of clinical jaundice between the HIV-exposed and HIV-non-exposed neonates. Contrary to our hypothesis, however, the incidence was greater in HIV-non-exposed than in HIV-exposed infants.

Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach

Recent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, and should be carefully reviewed concerning the potential presence of irritant constituents. In particular, cosmetic products used on the face, in vicinity of the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In this study, we aimed to evaluate the effect of a new cosmetic ingredient, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using reconstructed human epidermis, EpiSkin™, and human corneal epithelial model, SkinEthics™ HCE, and an in vivo assay. Three different extracts of CS were evaluated. The histology of the models after extracts applications was analysed. The in vitro results demonstrated that extracts were not classified as irritant and the histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantified after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can be regarded as safe for topical application.

Non-clinical isolates bring new findings on enterococcal virulence

Dissertation presented to obtain the PhD degree in Biology

La réponse au Farnésol de Candida albicans : production de biofilms et Parenté génétique

C. albicans est une levure pathogène opportuniste. Elle est un agent causal fréquent des infections muco-cutanées. C. albicans peut alterner entre la forme blastospore et mycélium. Cette dernière forme est impliquée dans la formation des biofilms. Le dimorphisme de C. albicans est contrôlé en partie par le phénomène de perception du quorum (quorum sensing) qui en autre, est associé à la molécule farnésol, produit par cette levure. La présence de cette molécule, inhibe la formation d’hyphe par C. albicans et par conséquent limite la formation de biofilms. Certaines souches ne répondent pas au farnésol et nous avons vérifié les hypothèses que : 1) la proportion des Non-Répondeurs (NR) au farnésol est similaire entre les souches de provenance orale et vaginale; 2) la capacité de formation de biofilm varie d’une souche à une autre mais les Non-Répondeurs en produisent en plus grande quantité; 3) la technique RAPD-PCR permettra de regrouper les souches de cette levure suivant leur provenance, leur capacité de formation de biofilm et leur aptitude à répondre au farnésol. La découverte d’une souche vaginale Non-Répondeur nous permet de croire que la proportion de ces souches est similaire entre les deux types de provenance. Les souches caractérisées Non-Répondeurs produisent 30 % plus de biofilm que les Répondeurs en absence de farnésol exogène dans le milieu. En présence de farnésol exogène, les Non-Répondeurs produisent 70 % plus de biomasse que les Répondeurs. De plus, la technique RAPD ne nous a pas permis de classer nos souches d’après les caractéristiques proposées. En conclusion, les souches orales de C. albicans semblent produire en moyenne plus de biomasse que les souches vaginales. Aussi, les NR semblent moins affectés par la présence du farnésol, ce qui pourrait causer la présence de biofilms tenaces. Les amorces utilisées pour la technique RAPD n’ont pas été efficace à la classification des souches dépendamment de leur provenance, de leur capacité à former un biofilm et à répondre au farnésol. Mots clés : Candida albicans, biofilm, perception du quorum (quorum sensing), farnésol, Non-Répondeur

Comparaison de la perception de la douleur entre le traitement orthodontique avec Invisalign® et le traitement avec fils et boîtiers fixes

Introduction : L’inconfort causé par les appareils orthodontiques peut significativement affecter la coopération des patients dans leur traitement. La douleur, ainsi que la détérioration de la fonction (mastication, élocution) sont reconnus comme les déterminants majeurs de la coopération des patients traités par appareils amovibles. Invisalign® se positionne comme une alternative esthétique aux multiples inconforts observés lors des traitements fixes avec boîtiers. À ce jour, peu d’études ont cherché à comparer la douleur (quantitativement et qualitativement) perçue entre cette technique et celle avec boîtiers fixes sur une longue période. Objectif : L’objectif de la présente étude est d’évaluer la douleur ressentie par les patients qui suivent un traitement orthodontique avec coquilles correctrices Invisalign® et de la comparer avec celle des patients qui suivent un traitement orthodontique conventionnel avec des boîtiers fixes. Matériels et Méthodes: L’étude compte 70 patients (29 garçons, 41 filles), moyenne d’âge de 16 ans [11 à 30]. Les trois sous-groupes sont Invisalign® (n=31), boîtiers Damon (n=19) et boîtiers Speed (n=20). Les groupes avec boîtiers (Damon et Speed) sont les 2 groupes de l’étude menée au sein de la clinique d’Orthodontie de l’Université de Montréal en 2011 qui comparait la perception de la douleur durant le traitement orthodontique entre boîtiers auto-ligaturants passifs et actifs. L’étude a été organisée en 4 phases correspondant à l’insertion des 4 premiers fils pour les groupes avec boîtiers (Phase 1: 0,016" Supercable, Phase 2: 0,016" CuNiTi, Phase 3: 0,016"x0,022" CuNiTi, Phase 4: 0,019"x0,025" CuNiTi) et à l’insertion des coquilles 1, 4, 7 et 10 pour le groupe Invisalign®. À l’aide d’un questionnaire, l’étude évalue pour chaque phase l’ampleur (grâce à une échelle visuelle analogue EVA), la durée et la localisation de la douleur à 6 différents points (T1: immédiatement après l’insertion, T2: 5h après, T3: 24h après, T4: 3 jours après, T5: une semaine après, T6: 2 semaines après). Résultats: À T1Ph3 le pourcentage de patients rapportant de la douleur était plus élevé avec Damon qu’avec Invisalign® (p=0,032) (Damon=55,6% ; Invisalign®=23,3%) mais il n’y avait pas de différence avec le groupe Speed (p=0,114). Les patients avec Invisalign® rapportaient significativement moins d’irritation des tissus mous (muqueuses, gencives) que les patients avec des boîtiers. Pour les résultats des EVA, les différences étaient statistiquement significatives à 2 temps : T3Ph1 (Médiane Invisalign®=33,31, Médiane Speed=49,47; p=0,025) et T3Ph4 (Médiane Invisalign®=13,15, Médiane Damon=27,28; p=0,014). Pour la majorité des patients la douleur ne nécessitait pas la prise de médicament et il n’y avait pas de différence significative entre les groupes sur ce point. La qualité de vie était légèrement affectée lors de la première phase et moindrement pour le groupe Invisalign® que pour les groupes avec boîtiers. Pour les patients Invisalign®, la douleur atteignait son niveau le plus élevé entre 5 et 24 heures après l’insertion de la première coquille, et diminuait en intensité et en durée à chaque phase. Conclusion: La perception de la douleur lors d’un traitement orthodontique avec Invisalign® est inférieure à celle ressentie lors d’un traitement avec des boîtiers fixes. Cette méthode de traitement est donc une thérapie attirante pour les patients désirant un traitement esthétique et relativement confortable.

Genotipificación de HLA-B en pacientes colombianos afectados por el síndrome Stevens-Johnson y la Necrólisis Epidérmica Tóxica

Las reacciones alérgicas a medicamentos cutáneas severas (RAM) como el Síndrome Stevens Johnson (SJS) y la Necrólisis Epidérmica Tóxica (NET),caracterizadas por exantema, erosión de la piel y las membranas mucosas, flictenas, desprendimiento de la piel secundario a la muerte de queratinocitos y compromiso ocular. Son infrecuentes en la población pero con elevada morbi-mortalidad, se presentan luego de la administración de diferentes fármacos. En Asia se ha asociado el alelo HLA-B*15:02 como marcador genético para SJS. En Colombia no hay datos de la incidencia de estas RAM, ni de la relación con medicamentos específicos o potenciales y tampoco estudios de aproximación genómica de genes de susceptibilidad.

Horses naturally infected by Trypanosoma vivax in southern Brazil

In this study, we reported the first outbreak of the infection by Trypanosoma vivax in horses in southern Brazil, a non-endemic region where bovines have only recently been found infected by this trypanosome species. We evaluated 12 horses from a farm in southern Brazil, where four horses displayed pale mucous membranes, fever, weight loss, and swelling of abdomen, prepuce, or vulva. The diagnosis of T vivax was confirmed in four horses by morphological parameters of trypomastigotes in blood smears and species-specific PCR. All T vivax-infected animals showed anemia, and most showed increased levels of beta-1, beta-2, and gamma globulins. Horses were treated with diminazene aceturate, but cure was not achieved, and the disease relapsed after therapy. These findings demonstrated that Brazilian T vivax isolates, which were already reported infecting cattle, buffaloes, goats, and sheep, can be highly pathogenic for horses, causing severe disease and even death of the animals due to the recurrence of the infection.

Infection by Trypanosoma vivax in goats and sheep in the Brazilian semiarid region: From acute disease outbreak to chronic cryptic infection

A study was undertaken to investigate the role of Trypanosoma vivax in sheep and goat mortality and abortions in the Brazilian semiarid region, where outbreaks Had been previously reported in bovines. For this purpose, 177 goats and 248 sheep (20% of herds) were randomly sampled on four farms in the State of Paraiba in May and October 2008. The animals were screened for trypanosomes by the buffy coat technique (BCT) and PCR. Infected animals, similar to 25% in both surveys, manifested apathy, pale mucous membranes, enlarged lymph nodes, weakness, weight loss, opacity of the cornea, blindness and abortion. However, the animals with acute and severe disease showing the highest levels of parasitemia and fever, which many times resulted in death, were only detected in the first survey. These severely diseased animals exhibited progressive weight loss and had the smallest packed cell volume (PCV) values. During survey 2, done in October 2008 on the same farms, only animals with low parasitemia and normal temperatures, PCV values and body weights were detected. Therefore, animals that spontaneously recovered from acute infection developed chronic and asymptomatic disease. This finding demonstrated for the first time that sheep and goats, which are the most important livestock in the semiarid region of Brazil, may be severely injured by T. vivax infection and also play a role as asymptomatic carriers and important sources of T. vivax to ruminants in general. Published by Elsevier B.V.

Experimental acute canine monocytic ehrlichiosis: clinicopathological and immunopathological findings

Clinical signs, humoral and cellular immune responses, and microscopic and gross tissue alterations resulting from acute experimental Ehrlichia canis infection in dogs were studied. Four dogs were inoculated with E canis and four were used as uninfected controls. After a 10-14-day incubation period, infected dogs developed pyrexia up to 41 degreesC for 6-8 days. Antibody titers to E. canis antigen were demonstrable in all inoculated dogs at 30 days post-infection. Necropsy of infected animals revealed pale mucous membranes, generalized lymphadenopathy, splenomegaly, edema and ascites. Microcopically, the main lesions were: lymphoreticular hyperplasia in cortical areas of lymph nodes and spleenic white pulp, periportal accumulation of mononuclear cells and centrolobular fatty degeneration of the liver. Kidneys presented with glomerulonephritis characterized by interstitial, mononuclear infiltration. Immunophenotyping of lymphocytes from lymph nodes and spleen sections displayed alterations in IgG, IgM, CD3+ and CD8+ cells population in infected dogs. (C) 2003 Elsevier B.V. All rights reserved.